XOMA Co. (NASDAQ:XOMAO) Short Interest Update

XOMA Co. (NASDAQ:XOMAO) was the recipient of a significant decrease in short interest in the month of March. As of March 13th, there was short interest totaling 3,423 shares, a decrease of 38.2% from the February 26th total of 5,537 shares. Based on an average daily volume of 1,474 shares, the short-interest ratio is presently 2.3 days.

XOMA Price Performance

XOMAO stock opened at $25.38 on Friday. The company’s 50-day moving average is $25.39 and its 200-day moving average is $25.42. XOMA has a 1 year low of $23.32 and a 1 year high of $25.76.

XOMA Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Thursday, April 2nd will be issued a $0.5234 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $2.09 annualized dividend and a yield of 8.2%.

About XOMA

XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.

In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.